Matthew Cohen

Matthew Cohen is a Managing Partner at Osage University Partners (OUP), a venture capital firm. See sector focus and contact routes.

About Matthew Cohen

Matthew Cohen is a Managing Partner at Osage University Partners (OUP), a venture capital firm, where he joined in 2013 and co-manages the firm’s life science investment activities alongside Bill Harrington, M.D.. His investment thesis focuses on therapeutics, diagnostics, medical devices, and research tools, primarily sourcing cutting-edge technologies from university research. While specific check sizes and lead/follow behavior are not publicly detailed, Cohen oversees and approves all Partnership investments as part of his managing partner responsibilities. Notable portfolio companies he has been involved with include Biohaven Pharma (NYSE: BHVN), Synthorx (acquired by Sanofi), Kura Oncology (NASDAQ: KURA), and Sana Biotechnology (NASDAQ: SANA). Cohen holds a Ph.D. in Cell and Molecular Biology from the University of Pennsylvania and previously worked as a strategy consultant at L.E.K. Consulting serving biopharma and private equity clients. He currently sits on the boards of Coho Therapeutics and IMMvention Therapeutix and serves as a board observer at Arrakis Therapeutics and Faraday Pharma. No distinctive public writing or unique point of v

Matthew Cohen at a glance

Role
Managing Partner
Organization
OUP (Osage University Partners)
Location
Bala Cynwyd, Pennsylvania, United States
Investor type
Venture Capital
Focus areas
Healthcare

Frequently asked about Matthew Cohen

What does Matthew Cohen invest in?
Matthew Cohen at OUP (Osage University Partners) (Bala Cynwyd, Pennsylvania, United States) — sector focus: Healthcare.
How do I contact Matthew Cohen?
Matthew Cohen's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Matthew Cohen based?
Matthew Cohen is based in Bala Cynwyd, Pennsylvania, United States.

StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Bala Cynwyd.

Investors similar to Matthew Cohen (20)

Browse related investor lists (1)

Compare Matthew Cohen (8)

Investors like Matthew Cohen · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades